AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,735.00
Bid: 7,728.00
Ask: 7,730.00
Change: 55.00 (0.72%)
Spread: 2.00 (0.03%)
Open: 7,682.00
High: 7,745.00
Low: 7,673.00
Yest. Close: 7,680.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

TOP NEWS: AstraZeneca Prices USD3 Billion Global Bond Offer

Tue, 4th Aug 2020 08:41

(Alliance News) - AstraZeneca on Tuesday said it priced a three-tranche global bond offering totalling USD3.00 billion, expected to close on Thursday.

The proceeds of the bond issue will be used for general corporate purposes which may include the refinancing of existing debts, the pharmaceutical company said.

AstraZeneca had net debt of GBP13.7 million at June 30, only slightly up from last year's GBP13.1 million.

The bond comes after AstraZeneca last week posted positive revenue growth in the six months ended June 30. The Cambridge-based company saw a 14% revenue increase in the half to USD12.63 billion from USD11.31 billion a year prior. Pretax profit was USD1.89 billion, doubled from USD899 million the year prior.

The bond offer is a global one registered with the US Securities Exchange Commission.

The three tranches are as follows: USD1.20 billion of fixed rate notes with a coupon of 0.7%, maturing April 8, 2026; USD1.30 billion of fixed rate notes with a coupon of 1.4%, maturing August 6, 2030; and USD500.0 million of fixed rate notes with a coupon of 2.1%, maturing August 6, 2050.

BofA Securities Inc, HSBC Securities Inc and Mizuho Securities USA LLC are acting as joint book-running managers. Barclays Capital Inc, Citigroup Global Markets Inc, Deutsche Bank Securities Inc, Goldman Sachs & Co LLC, JP Morgan Securities LLC and Morgan Stanley and Co LLC are co-managers on the transaction.

The bond issuance does not affect the company's guidance for 2020, it said.

AstraZeneca shares were down 2.0% at 8,591.00 pence each on Tuesday morning in London.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

INSIGHT-How the U.S. locked up vaccine materials other nations urgently need

By Allison Martell and Euan RochaMay 7 (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.As a result, the U.S. government laid claim n...

Today 16:00

WRAPUP 1-Britain, Germany in role reversal on AstraZeneca vaccine risks

* Britain restricts AstraZeneca to people aged over 40* In Germany, all adults free to get AZ shot on doctor's advice* Germany, with eye on summer hols, shortens gap between doses* EU regulator looking at AZ on reports of neurological illnessBy Al...

Today 15:34

UPDATE 1-Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

(Adds details and background)By Khanh VuHANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot, as the country is battling a new outbreak.A 35-year-old fe...

Today 15:31

Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

HANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot.A 35-year-old female health worker in the southern province of An Giang died on Friday, one day aft...

Today 14:54

UPDATE 1-EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

(Adds details from EMA statement on other vaccines, background)May 7 (Reuters) - Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's COVID-19 vaccine,...

Today 13:15

UPDATE 2-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviewing AstraZeneca vaccine for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA also assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (...

Today 13:15

UPDATE 3-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviews AstraZeneca shot for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (Adds BioNTe...

Today 13:15

Canada willing to discuss COVID-19 vaccine IP waiver -statement

OTTAWA, May 7 (Reuters) - Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in devel...

Today 13:00

UPDATE 1-German panel to recommend J&J COVID vaccine for over-60s - Spiegel

(Adds RKI comment, background)BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing...

Today 12:24

Germany's STIKO to recommend J&J COVID vaccine for over-60s - Spiegel

BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources.Europe's drug regu...

Today 11:58

New UK guidance on AstraZeneca will not affect rollout schedule- official

LONDON, May 7 (Reuters) - Britain's decision to advise all under 40-year-olds to take an alternative vaccine to the Oxford/AstraZeneca one will not affect the country's plan to offer a first dose to all adults by the end of July, a senior health ...

Today 11:43

UPDATE 1-Third wave of pandemic "appears to be broken" - German health minister

(Adds detail on vaccination progress, AstraZeneca decision)BERLIN, May 7 (Reuters) - The third wave of the coronavirus pandemic appears to be broken, German Health Minister Jens Spahn said on Friday, as social distancing measures and an accelerati...

Today 09:54

UPDATE 2-Germany defends AstraZeneca pivot as key to speeding vaccinations

* All adults now free to get AZ shot, on doctor's advice* Gap between doses can be as little as 4 weeks* Experts warn on reduced efficacy with shorter gap* Third wave of pandemic "appears to be broken" - minister (Recasts to lead on AstraZeneca shif...

Today 09:54

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Today 09:49

Germany says production capacity, not patents, key to upping vaccine output

BERLIN, May 7 (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive pate...

Today 09:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.